000301:SZSEJiangsu Eastern Shenghong Co.,Ltd. Analysis
Data as of 2026-03-17 - not real-time
CN¥11.33
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
Jiangsu Eastern Shenghong is trading at CNY 11.33, comfortably above its 200‑day SMA of 9.92 but still below the 20‑day and 50‑day SMAs (12.68 and 12.02), indicating a price that has not yet reclaimed short‑term momentum. The stock sits just above the calculated support of 11.01 and well under the resistance near 14.70, while the RSI of 38.7 hints at a mildly oversold condition. However, the MACD histogram remains negative and the MACD signal is flagged as bearish, suggesting continued downside pressure despite the recent uptick in volume. Volatility is elevated at over 57 % for the past 30 days, yet the beta is exceptionally low (0.04), implying limited correlation with broader market moves.
Fundamentally, the company is under stress: revenue fell 11.9 % YoY, profit margins are negative (-0.6 %), and the debt‑to‑equity ratio is astronomical at 398 ×. While cash balances are sizable (CNY 17.7 bn), total debt exceeds CNY 150 bn, and free cash flow is negative. The DCF‑derived fair value of CNY 7.32 is far below the market price, yielding a modest downside of about ‑1 %. The recent state approval for an imported crude‑oil quota could lift top‑line volumes, but the heavy leverage and weak profitability keep the valuation stretched, as reflected by a forward P/E of 62.9×.
Fundamentally, the company is under stress: revenue fell 11.9 % YoY, profit margins are negative (-0.6 %), and the debt‑to‑equity ratio is astronomical at 398 ×. While cash balances are sizable (CNY 17.7 bn), total debt exceeds CNY 150 bn, and free cash flow is negative. The DCF‑derived fair value of CNY 7.32 is far below the market price, yielding a modest downside of about ‑1 %. The recent state approval for an imported crude‑oil quota could lift top‑line volumes, but the heavy leverage and weak profitability keep the valuation stretched, as reflected by a forward P/E of 62.9×.
Market Outlook
Short Term
< 1 yearCautious
Model confidence: 7/10
Key Factors
- Bearish MACD and negative histogram
- Proximity to support level with limited upside
- Extremely high debt burden
Medium Term
1–3 yearsNeutral
Model confidence: 6/10
Key Factors
- Forward EPS improvement and state‑approved crude quota
- Continued earnings volatility and negative free cash flow
- Low market beta reducing systemic risk
Long Term
> 3 yearsNeutral
Model confidence: 5/10
Key Factors
- Potential restructuring of debt and asset base
- Low price‑to‑sales ratio offering value upside if margins recover
- Fundamental exposure to cyclical chemicals market
Key Metrics & Analysis
Financial Health
Revenue Growth-11.90%
Profit Margin-0.62%
P/E Ratio62.9
ROE-2.05%
ROA0.61%
Debt/Equity397.81
P/B Ratio2.2
Op. Cash FlowCN¥18.9B
Free Cash FlowCN¥-1847124352
Technical Analysis
TrendBullish
RSI38.7
SupportCN¥11.01
ResistanceCN¥14.70
MA 20CN¥12.68
MA 50CN¥12.02
MA 200CN¥9.92
MACDBearish
VolumeIncreasing
Fear & Greed Index81.48
Valuation
Fair ValueCN¥7.32
Target PriceCN¥11.20
Upside/Downside-1.15%
GradeOvervalued
TypeBlend
Risk Assessment
Beta0.04
Volatility57.09%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.